Matrix Metalloproteinases-2, -3, -7, -9 and -10, But Not MMP-11, Are Differentially Expressed in Normal, Benign Tumorigenic and Malignant Human Keratinocyte Cell Lines

Biological Chemistry

Volumn 381, Issue 5-6, 2000, Pages 497-507

  Bachmeier, Beatrice E ^a   Fink, Edwin ^a   Boukamp, Petra ^b   Fusenig, Norbert E ^b   Lichtinghagen, Ralf ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Collagenases; Gelatinases; HaCaT cells; Matrilysin; Stromelysins

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3;

ARTICLE; BENIGN TUMOR; CANCER CELL CULTURE; CARCINOGENICITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ZYMOGRAPHY;

BASE SEQUENCE; BLOTTING, WESTERN; CELL EXTRACTS; CELL LINE; CELL LINE, TRANSFORMED; CULTURE MEDIA, CONDITIONED; DNA PRIMERS; GELATIN; HUMANS; KERATINOCYTES; MATRIX METALLOPROTEINASES; RNA, MESSENGER;

EID: 0033947843     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2000.064     Document Type: Article

References (45)

1. Bernhard, E. J., Gruber, S. B., and Muschel, R. J. (1994). Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA 91, 4293-4297.
2. Bolon, I., Brambilla, E., Vandenbunder, B., Robert, C., Lantuejoul, S., and Brambilla, C. (1996). Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions. Lab. Invest. 75, 1-13.
3. Bolon, I., Devouassoux, M., Robert, C., Moro, D., Brambilla, C., and Brambilla, E. (1997). Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas. Am. J. Pathol. 150, 1619-1629.
4. Borchers, A. H., Powell, M. B., Fusenig, N. E., and Bowden, G. T. (1994). Paracrine factor and cell-cell contact-mediated induction of protease and c-ets gene expression in malignant ker-atinocyte/dermal fibroblast cocultures. Exp. Cell. Res. 213, 143-147.
5. Borchers, A. H., Steinbauer, H., Schafer, B. S., Kramer, M., Bowden, G. T., and Fusenig, N. E. (1997). Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma. Mol. Carcinogen. 19, 258-266.
6. Boukamp, P., Petrussevska, R. T., Breitkreutz, D., Hornung, J., Markham, A., and Fusenig, N. E. (1988). Normal keratinization in a spontaneously immortalized aneuploid human keratino-cyte cell line. J. Cell Biol. 106, 761-771.
7. Boukamp, P., Stanbridge, E. J., Foo, D. Y., Cerutti, P. A., and Fusenig, N. E. (1990). c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth in vivo but lacks correlation with malignancy. Cancer Res. 50, 2840-2847.
8. Chambers, A. F., and Matrisian, L. M. (1997). Changing views of the role of matrix metalloproteinases in metastasis. J. Nat. Cancer Inst. 89, 1260-1270.
9. Chomczynsky, P., and Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. Heussen, C., and Dowdle, E. B. (1980). Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102, 196-202.
11. Itoh, T., Tanioka, M., Yoshida, H., Yosioka, T., Nishimoto, H., and Itohara, S. (1998). Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58, 1048-1051.
12. Karameris, A., Panagou, P., Tsilalis, T., and Bouros, D. (1997). Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas-a molecular and immunohistochemical study. Am. J. Respir. Crit. Care Med. 156, 1930-1936.
13. Khokha, R., Waterhouse, P., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., and Denhardt, D. T. (1989). Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 243, 947-950.
14. Knox, J. D., Mack, C. F., Powell, W. C., Bowden, G. T., and Nagle, R. B. (1993). Prostate tumor cell invasion: a comparison of orthotopic and ectopic models. Invas. Metast. 13, 325-331.
15. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., and Groom, A. C. (1994). Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res. 54, 4791-4797.
16. Liaw, L., and Crawford, H. C. (1999). Functions of the extracellular matrix and matrix degrading proteases during tumor progression. Braz. J. Med. Biol. Res. 32, 805-812.
17. Lichtinghagen, R., Helmbrecht, T., Arndt, B., and Boker, K. H. W. (1995). Expression pattern of matrix metalloproteinases in human liver. Eur. J. Clin. Chem. Clin. Biochem. 33, 65-71.
18. Lochter, A., Srebrow, A., Sympson, C. J., Terracio, N., Werb, Z., and Bissell, M. J. (1997). Misregulation of stromelysin-1 expression in mouse mammary tumor cells accompanies acquisition of stromelysin-1-dependent invasive properties. J. Biol. Chem. 272, 5007-5015.
19. Masson, R., Lefebvre, O., Noel, A., Fahime, M. E., Chenard, M. P., Wendling, C., Kebersnc, F., LeMeur, M., Dierich, A., Foidart, J. M., Basset, P., and Rio, M. C. (1998). In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignay. J. Cell Biol. 140.
20. Meade-Tollin, L. C., Boukamp, P., Fusenig, N. E., Bowen, C. P. R., Tsang, T. C., and Bowden, G. T. (1998). Differential expression of matrix metalloproteinases in activated c-ras(Ha)-transfected immortalized human keratinocytes. Brit. J. Cancer 77, 724-730.
21. Mignatti, P., and Rifkin, D. B. (1993). Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
22. Morris, V. L., Koop, S., MacDonald, I. C., Schmidt, E. E., Grattan, M., Percy, D., Chambers, A. F., and Groom, A. C. (1994). Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin. Exp. Metast. 12, 357-367.
23. Muller, D., Wolf, C., Abecassis, J., Millon, R., Engelmann, A., Bronner, G., Rouyer, N., Rio, M. C., Eber, M., Methlin, G. et al. (1993). Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res. 53, 165-169.
24. Munck-Wikland, E., Heselmeyer, K., Lindholm, J., Kuylenstierna, R., Auer, G., and Engel, G. (1998). Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx. Int. J. Oncol. 12, 859-864.
25. Nagase, H. (1995). Stromelysins 1 and 2. Meth. Enzymol. 248, 449-484.
26. Noël, A., Gilles, C., Bajou, K., Devy, L., Kebers, F., Lewalle, J. M., Maquoi, E., Munaut, C., Remacle, A., and Foidart, J. M. (1997). Emerging roles for proteinases in cancer. Invas. Metast. 17, 221-239.
27. Pei, D., and Weiss, S. J. (1998). Stromelysin 3. In: Handbook of Proteolytic Enzymes, A. J. Barrett, N. D. Rawlings and J. F. Woessner, eds. (London, UK: Academic Press), pp. 1187–1190.
28. Polette, M., Clavel, C., Muller, D., Abecassis, J., Binninger, I., and Birembaut, P. (1991). Detection of mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the head and neck by in situ hybridization. Invas. Metast. 11, 76-83.
29. Porte, H., Chastre, E., Prevot, S., Nordlinger, B., Empereur, S., Basset, P., Chambon, P., and Gespach, C. (1995). Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes. Int. J. Cancer. 64, 70-75.
30. Powell, W. C., Knox, J. D., Navre, M., Grogan, T. M., Kittelson, J., Nagle, R. B., and Bowden, G. T. (1993). Expression of the metal-loproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res. 53, 417-422.
31. Pyke, C., Ralfkiaer, E., Huhtala, P., Hurskainen, T., Dano, K., and Tryggvason, K. (1992). Localization of messenger RNA for Mr 72, 000 and 92, 000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 52, 1336-1341.
32. Ray, J. M., and Stetler-Stevenson, W. G. (1994). The role of metal-loproteases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J. 7, 2062-2072.
33. Rouyer, N., Wolf, C., Chenard, M. P., Rio, M. C., Chambon, P., Bellocq, J. P., and Basset, P (1994). Stromelysin-3 gene expression in human cancer: an overview. Invas. Metast. 14, 269-275.
34. Schmitt, M., Jänicke, F., and Graeff, H. (1992). Tumor-associated proteases. Fibrinolysis, 6 Supplement 4, 3-26.
35. Schultz, R. M., Silberman, S., Persky, B., Bajkowski, A. S., and Carmichael, D. F. (1988). Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res. 48, 5539-5545.
36. Silberman, S., Janulis, M., and Schultz, R. M. (1997). Characterization of downstream Ras signals that induce alternative protease-dependent invasive phenotypes. J. Biol. Chem. 272, 5927-5935.
37. Sloane, B. F., and Berquin, I. M. (1993). Proteases and cancer: an introduction. In: Proteolysis and Protein Turnover, J. S. Bond and A. J. Barrett, eds. (London, UK: Portland Press), pp. 225–231.
38. Stetler-Stevenson, W. G., Liotta, L. A., and Kleiner, D. E. (1993). Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7, 1434-1441.
39. Tetu, B., Brisson, J., Lapointe, H., and Bernard, P (1998). Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer. Hum. Pathol. 29, 979-985.
40. von Marschall, Z., Riecken, E. O., and Rosewicz, S. (1998). Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut 43, 692-698.
41. Watanabe, M., Takahashi, Y., Ohta, T., Mai, M., Sasaki, T., and Seiki, M. (1996). Inhibition of metastasis in human gastric cancer cells transfected with tissue inhibitor of metalloproteinase 1 gene in nude mice. Cancer 77, 1676-1680.
42. Werb, Z., Ashkenas, J., MacAuley, A., and Wiesen, J. F. (1996). Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz. J. Med. Biol. Res. 29, 1087-1097.
43. Woessner, J. F. J. (1995). Quantification of matrix metalloproteinases in tissue samples. Meth. Enzymol. 248, 510-528.
44. Wright, J. H., McDonnell, S., Portella, G., Bowden, G. T., Balmain, A., and Matrisian, L. M. (1994). A switch from stromal to tumor cell expression of stromelysin-1 mRNA associated with the conversion of squamous to spindle carcinomas during mouse skin tumor progression. Mol. Carcinog. 10, 207-215.
45. Zhang, J. Y., and Schultz, R. M. (1992). Fibroblasts transformed by different ras oncogenes show dissimilar patterns of protease gene expression and regulation. Cancer Res. 52, 6682-6689.